Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid
Introduction Primary biliary cholangitis (PBC) is a rare chronic cholestatic disease that despite current therapy has significant ongoing unmet needs, including risks of cirrhosis and life-impairing symptoms. The current treatment approach is a step-up model, wherein first-line therapy, ursodeoxycho...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2026-03-01
|
| Serier: | BMJ Open |
| Online adgang: | https://bmjopen.bmj.com/content/16/3/e113812.full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
